Michael Makris: 3 PTP Haemophilia A in Japan Have Developed FVIII Inhibitors Following Treatment with Efanesoctocog Alfa
Michael Makris, Emeritus Professor of Haemostasis and Thrombosis at the University of Sheffield, shared on LinkedIn:
“Three Previously Treated Haemophilia A Patients (PTPs) in Japan have developed FVIII inhibitors following treatment with efanesoctocog alfa (Altuviiio/Altuvoct). One had severe haemophilia, and the other two had moderate and mild disease. Only 38 patients were exposed to efanesoctocog alfa in the centres these 3 patients were reported from.
This is a very much higher rate than expected, and the reasons are unclear.
Was it chance? We will know very soon, as this drug is now used extensively in PTP haemophilia A patients around the world.”
Title: The First Three Japanese Haemophilia A Patients in Whom Factor VIII Inhibitors Were Observed During Prophylactic Treatment With Efanesoctocog Alfa
Authors: Tazuko Tokugawa, Akihiro Sawada, Satoshi Higasa, Mariko Asai, Hideyuki Nakazawa, Azusa Nagao, Tomoko Yamaguchi, Yushi Chikasawa, Masato Bingo, Takeshi Hagiwara, Katsuyuki Fukutake
Read more posts from Michael Makris in Hemostasis Today.
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies
-
May 26, 2026, 15:22Shazmah Shaikh: One Visual Guide to Understand All Major Anticoagulants
-
May 26, 2026, 14:39Chidinma Favour։ Welcome to Day 25 of My 31-Day Stroke Awareness Series
-
May 26, 2026, 14:35Novel Insights Into Congenital and Acquired Coagulopathies – ICHCC
-
May 26, 2026, 14:24Fernanda Orsi: The Growing Impact of Hematology Research in Latin America
-
May 26, 2026, 14:23Rense Buijvoets: What If Clots Could Be Treated Exactly Where They Form?